{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-175433","form_type":"8-K","ticker":"AVIR","cik":"0001593899","company_name":"Atea Pharmaceuticals, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.453714+00:00","generated_at":"2026-05-17T17:35:54.034294+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Atea Q2 net loss $37.2M ($0.44/shr); cash $379.7M; repurchases shares; strategic review ongoing","bullets":["Net loss of $37.2M ($0.44 diluted EPS) vs $40.5M loss in Q2 2024; R&D expense $32.3M, down $2.4M YoY.","Cash, equivalents and marketable securities $379.7M at June 30, 2025, down from $454.7M at Dec 31, 2024.","Board authorized up to $25M share repurchase; 4.6M shares bought at avg $3.01 through June 30.","Engaged Evercore to evaluate strategic alternatives including partnerships, M&A, or sale of assets.","Global Phase 3 HCV program (C-BEYOND, C-FORWARD) enrolling on track; 98% SVR12 in Phase 2 per-protocol population."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-175433","json":"https://secwatch.observer/filing/0001193125-25-175433.json","markdown":"https://secwatch.observer/filing/0001193125-25-175433.md","text":"https://secwatch.observer/filing/0001193125-25-175433.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525175433/0001193125-25-175433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525175433/d921944d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T17:35:54.034294+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}